5-Ethyl-imidazotriazinones

US7087605B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Ulrich Niewohner · Wermelskirchen, DE
• Heike Gielen · Leverkusen, DE
• Martin Hendrix · Tarrytown, US
• Dagmar Schauss · Wuppertal, DE
• Hilmar Bischoff · Wuppertal, DE
• Nils Burkhardt · Velbert, DE
• Volker Geiss · Ratingen, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Nigel J. Cuthbert · Tiverton, GB
• Mary F. Fitzgerald · Yarnton, GB
• Richard Graham Sturton · Maidenhead, GB
• Martin Michels · Solingen, DE
• Cristina Alonso-Alija · Haan, DE

Key dates

• Filing date: May 21, 2002
• Grant date: Aug 8, 2006
• Expiry date: Jul 9, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to novel 5-Ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.